Table 3.
Predictors of CRNA in Canada
Predictor | No. of articles reporting significance | Citations |
---|---|---|
Higher out-of-pocket costsa | 13 | [2, 3, 37, 39–41, 47, 50–53, 55, 56] |
Lower income or low financial flexibility | 9 | [3, 38–40, 43, 46, 48, 54, 55] |
Lack of drug insurance | 7 | [40, 41, 43, 46, 47, 54, 55] |
Younger age | 6 | [38–40, 43, 46, 47] |
Poor self-reported health status | 5 | [39, 40, 43, 46, 47] |
Province of residence (e.g., Ontario instead of Quebec, or British Columbia instead of Ontario or Quebec) | 4 | [38, 43, 46, 47] |
Several chronic health conditions | 2 | [38, 46] |
High cost of drugs | 2 | [35, 54] |
Low/medium drug importance from individual’s perspective | 2 | [54, 55] |
Not feeling involved in treatment decisions | 2 | [39, 55] |
First Nations status | 1 | [39] |
aIncludes studies comparing the rates of CRNA pre- and post-copayment policy